Search
for
Sort by
Research 271–300 of 822
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
- Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- sc-eQTL unveil immunogenetic architecture of polycystic ovary syndrome
- Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study<sup>1</sup>
- Developmental origin of polycystic ovary syndrome - a hypothesis
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Current Guidelines for Diagnosing PCOS
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- The diagnosis of polycystic ovary syndrome in adolescents
- Treatment of Hirsutism With Spironolactone
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Androgen excess is the key element in polycystic ovary syndrome
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Obesity and polycystic ovary syndrome
- Polycystic Ovarian Syndrome
- Diagnosis of hyperandrogenism: clinical criteria
- Current evaluation of amenorrhea
- MENSTRUAL DISORDERS IN ADOLESCENTS